Can a Two-Drug combo beat aspirin alone for preventing clots after joint surgery?

NCT ID NCT04075240

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This large, completed phase 3 trial enrolled over 5,400 people undergoing total hip or knee replacement to compare two approaches for preventing venous thromboembolism (blood clots). Participants received either aspirin alone or a short course of rivaroxaban followed by aspirin. The study measured how many developed symptomatic clots or experienced bleeding. The goal was to find a safer, more effective prevention strategy for this common surgery.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
rivaroxaban (Xarelto) and aspirin
What this could lead to
If successful, this could show that adding a short course of rivaroxaban to aspirin is a safe and effective way to prevent dangerous blood clots after joint replacement surgery.
What could go wrong
This trial is completed, so results are known. However, the benefit may be modest, and adding rivaroxaban increases bleeding risk. The findings may not apply to people with prior clots or other risk factors.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for VENOUS THROMBOEMBOLISM are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Queen Elizabeth II HSC

    Halifax, Nova Scotia, B3H 3A7, Canada

More trials for these conditions

Other studies related to the condition(s) this trial covers.